11/13/2024
4:01 PM | Eupraxia Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/08/2024
10:49 AM | Eupraxia Pharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
11/07/2024
4:17 PM | Eupraxia Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/31/2024
6:39 PM | Eupraxia Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/28/2024
6:02 AM | Eupraxia Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/15/2024
7:06 AM | Eupraxia Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/10/2024
6:01 AM | Eupraxia Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
|
09/19/2024
4:23 PM | Eupraxia Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/11/2024
6:02 AM | Eupraxia Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/04/2024
6:01 AM | Eupraxia Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/07/2024
4:14 PM | Eupraxia Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/02/2024
6:05 AM | Eupraxia Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/08/2024
6:01 AM | Eupraxia Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/05/2024
6:01 AM | Eupraxia Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/23/2024
4:04 PM | Eupraxia Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/22/2024
6:04 AM | Eupraxia Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/21/2024
4:05 PM | Eupraxia Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/15/2024
11:00 AM | Eupraxia Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/14/2024
6:04 AM | Eupraxia Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/02/2024
6:01 AM | Eupraxia Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/11/2024
6:02 AM | Eupraxia Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/10/2024
4:03 PM | Eupraxia Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2024
3:24 PM | Eupraxia Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2024
6:01 AM | Eupraxia Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/05/2024
4:04 PM | Eupraxia Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
04/05/2024
6:02 AM | Eupraxia Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/04/2024
1:59 PM | Eupraxia Pharmaceuticals (Filer)
| Form CERT | |
04/03/2024
4:00 PM | Eupraxia Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/18/2024
3:30 PM | Eupraxia Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/15/2024
3:48 PM | Eupraxia Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/12/2024
3:30 PM | Eupraxia Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/11/2024
4:27 PM | Eupraxia Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/07/2024
11:15 PM | Eupraxia Pharmaceuticals (Filer)
| Form EFFECT | |
02/05/2024
3:01 PM | Eupraxia Pharmaceuticals (Filer)
| Form F-10/A | |
01/18/2024
4:23 PM | Eupraxia Pharmaceuticals (Filer)
| Form 8-A12B | |
01/18/2024
3:30 PM | Eupraxia Pharmaceuticals (Subject)
| Form F-X
Appointment of agent for service of process and undertaking | |
